These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4303154)

  • 1. [Pharmacological inhibition and stimulation of ovulation].
    Tausk M
    Wien Klin Wochenschr; 1968 Jul; 80(29):561-7. PubMed ID: 4303154
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum luteinizing and follicle stimulating hormone levels during sequential and nonsequential contraceptive treatment of eugonadal women.
    Swerdloff RS; Odell WD
    J Clin Endocrinol Metab; 1969 Feb; 29(2):157-63. PubMed ID: 4179302
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ovulation inhibitors and ACTH reserve].
    Rindt W; Heinen G; Oertel GW
    Endokrinologie; 1971 Apr; 57(3):358-63. PubMed ID: 4325995
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanism of action of oral contraceptives.
    Tausk M
    Acta Obstet Gynecol Scand; 1969; 48(S1):41-56. PubMed ID: 4190601
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraceptives and follicle-stimulating hormone.
    Schmidt-Elmendorff H; Kopera H
    Lancet; 1968 Jun; 1(7553):1194-5. PubMed ID: 4172299
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral contraceptives and follicle-stimulating hormone.
    Cargille CM; Ross GT
    Lancet; 1968 Apr; 1(7548):924. PubMed ID: 4171528
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanism in inhibition of ovulation in oral contraception. II. The effect of PMS and HCG observed at laparotomy in patients treated with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone ogether with 17-alpha-ethynyl-oestradiol-3-methylether.
    Starup J; Ostergaard E
    Acta Endocrinol (Copenh); 1966 Jun; 52(2):292-304. PubMed ID: 5952708
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of a new ovulation inhibitor].
    Lecart C
    Schweiz Rundsch Med Prax; 1970 Jun; 59(25):933-6. PubMed ID: 5513424
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocrine properties and mechanism of action of oral contraceptives.
    Saunders FJ
    Fed Proc; 1970; 29(3):1211-9. PubMed ID: 4910270
    [No Abstract]   [Full Text] [Related]  

  • 10. [Personal experiences with Anacyclin].
    Vrobel T; Kovác R; Kovácová L
    Cesk Gynekol; 1973 May; 38(4):234-5. PubMed ID: 4717896
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of ovarian biopsies from women cyclically treated with the combination ethynodiol diacetate+mestranol alone and together with human menopausal gonadotrophin (Pergonal)+HCG.
    Pujol-Amat P; Urgell-Roca JM; Esteban-Altirriba J; Márquez-Ramirez M
    Gynaecologia; 1969; 167(4):237-49. PubMed ID: 5767877
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of the long term administration of oral contraceptives on excretion values for follicle-stimulating hormone and luteinising hormone.
    Bell ET; Herbst AL; Krishnamurti M; Loraine JA; Mears E; Jackson MC; Garcia CR
    Acta Endocrinol (Copenh); 1967 Jan; 54(1):96-104. PubMed ID: 6071215
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of various dosages of lynestrenol on the FSH, LH and total gonadotrophin activity during the menstrual cycle.
    Schmidt-Elmendorff H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):368-73. PubMed ID: 5510165
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypophysiotropic hormones of the hypothalamus].
    Schreiber V
    Ther Umsch; 1972 Sep; 29(9):518-22. PubMed ID: 4343768
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism in inhibition of ovulation in oral contraception. 3. The excretion of total pituitary gonadotrophins and luteinizing hormone in fertile women during cyclical treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone together with 17-alpha-ethynyl-oestradinol-3-methylether.
    Starup J; Lebech PE
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):188-96. PubMed ID: 6072686
    [No Abstract]   [Full Text] [Related]  

  • 16. A new progestogen-estrogen combination for gynecologic therapy and contraception.
    Linthorst G
    Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a new combination oral contraceptive: lynestrenol-mestranol (Lyndiol).
    Moses LE; Goldzieher JW; Moses IG
    Fertil Steril; 1969; 20(5):715-28. PubMed ID: 5822858
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies in the use of luteinizing hormone-follicle-stimulating hormone releasing hormone to induce ovulation in women.
    Bonnar J
    J Endocrinol; 1973 Aug; 58(2):XXXIV-XXXV. PubMed ID: 4580059
    [No Abstract]   [Full Text] [Related]  

  • 19. [Artificial induction of ovulation. I. Use of gonadotropins of human origin].
    Albeaux-Fernet M; Bellot L; Canet L; Deribreux J; Gelinet M
    Annee Endocrinol; 1970; 22():152-62. PubMed ID: 5485065
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytological effects of two contraceptives.
    Kabarity A; Khodari S
    Genetica; 1967; 38(2):184-90. PubMed ID: 5586876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.